Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Expression of synaptophysin and its mRNA in bovine corpus lutea during different stages of pregnancy

Zhang, W., Chen, S., Wang, Z., Tang, C., Meng, X., Li, F., & Zhao, S. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.10.024 · Cited by 2

EAAT4 mRNA expression is preserved in the cerebellum of prion protein-deficient mice

Yukitake, M., Satoh, J., Katamine, S., & Kuroda, Y. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.057 · Cited by 2

Excitotoxicity-Mediated Neurochemical Changes in Neurological Disorders

Farooqui, A. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-09693-3_6 · Cited by 2

Structural insights into human excitatory amino acid transporter EAAT2Preprint

Kato, T., Kusakizako, T., Jin, C., Quan, L., Ohgaki, R., Okuda, S., Kobayashi, K., Yamashita, K., Nishizawa, T., Kanai, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.03.465409 · Cited by 2

Ceftriaxone Treatment of TBI

Hameed, M. Q., & Rotenberg, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802686-1.00015-8 · Cited by 2

Plasma EAAT2 and GABA as candidate biomarkers in males with autism spectrum disorder: an exploratory case–control study with ROC analysis

El-Ansary, A. K., Alabdali, A. N., Bacha, A. G. B., Alonazi, M. A., AL-Ayadhi, L. Y., & Bjørklund, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-45737-1 · Cited by 2

Astrocytes and Their Role in the Development and Progression of Alzheimer’s Disease: Gatekeepers of Neurodegeneration

Svobodová, I., Bendová, Z., & Novotný, J. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin49765 · Cited by 2

Cycad consumption and neurological disease.

Schulz, J., Hawkes, E., & Shaw, C. A. (2005) · doi:10.1201/9781420037524-9 · Cited by 1

Cinco siglos circunnavegando el planeta

González, F. J. G. (2012) · Boletín de la Institución Libre de Enseñanza · Cited by 1

Role of Reactive Astrocytes in Alzheimer’s Disease

Sarkar, S., Guha, S., & Biswas, S. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_9 · Cited by 1

Glutamatergic Neurotransmission, Aluminium and Alzheimer’s Disease

Felipo, V. (2001) · Elsevier eBooks · doi:10.1016/b978-044450811-9/50042-2 · Cited by 1

FUNCTIONAL PROPERTIES OF L-GLUTAMATE REGULATION IN ANESTHETIZED AND FREELY MOVING MICE

Hascup, K. N. (2007) · UKnowledge (University of Kentucky) · Cited by 1

The 4b-4c loop of excitatory amino acid transporter 1 containing four critical residues essential for substrate transport

He, S., Zhang, W., Zhang, X., Xu, P., Hong, M., & Qu, S. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1664935 · Cited by 1

Remifentanil Suppresses Oxidative Stress and Inflammation Induced by Glutamate via Activation of PPARγ/HO-1 Signaling Pathway in Hippocampal Neuronal Cells

Liu, W., Wang, X., Du, L., & Sun, Y. (2021) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2021.2782 · Cited by 1

Glutamate Receptors and Excitotoxic Mechanisms in Alzheimer’s Disease

Geddes, J. W. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_18 · Cited by 1

Regulation of excitotoxicity in thiamine deficiency : role of glutamate transporters

Jhala, S. S. (2012) · doi:10.71781/32236 · Cited by 1

Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor

Cassano, T., Carratù, M. R., Coluccia, A. M. L., Giovanni, V. D., Steardo, L., Cuomo, V., & Trabace, L. (2002) · Drug Development Research · doi:10.1002/ddr.10088 · Cited by 1

Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer’s Disease Brain and in Brain from a Rodent Model of Familial Parkinson’s Disease: Insights into Potential Mechanisms of Neurodegeneration

Rukhsana Sultana, A., Poon, H. F., & Butterfield, D. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_15 · Cited by 1

Proteomics Identification of Oxidatively Modified Proteins in the Alzheimer’s Disease Brain and Models Thereof

Butterfield, D. A., Rukhsana Sultana, A., & Poon, H. F. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch1 · Cited by 1

Faculty Opinions recommendation of A vicious cycle of β amyloid-dependent neuronal hyperactivation.

Hell, J. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736365538.793564339 · Cited by 1

Editorial: The role of inflammation in neurodegenerative and psychiatric disorders

Hermann, D. M., Zhang, M., Huang, A., & Teng, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1574274 · Cited by 1

Neurotransmitterveränderungen bei der Alzheimer Demenz

Kornhuber, J., Gundacker, I., Maler, M., Otto, M., & Wiltfang, J. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_5 · Cited by 1

Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease

Chimal-Juárez, E., Patel, H., Jury-Garfe, N., Dabin, L. C., Vidal, R., Kim, J., & Lasagna-Reeves, C. A. (2026) · bioRxiv · doi:10.64898/2026.05.12.724684

Surface diffusion of the astrocytic glutamate transporter glt-1 shapes synaptic transmission

Murphy‐Royal, C. (2014) · HAL · doi:10.70675/0287b5c6z4aa6z4202z932fzc6de87cc37ef

The Role of Glutaminase 1 in HIV-1 Associated Neurocognitive Disorders and in Brain Development

Wang, Y. (2015) · DigitalCommons@UNMC

Peripheral Biomarkers of Excitotoxicity in Neurological Diseases

Tremolizzo, L., Sala, G., & Ferrarese, C. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_7

Novel Therapeutic Approaches to Malignant Gliomas

Cuddapah, V. A., & Sontheimer, H. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_14

Effect of proinflammatory activation on the neurosupportive functions of astrocytes

Steele, M. L. (2011)

VEGF treatment during status epilepticus alters long-term hippocampal astrocyte morphology: A detailed description of astrocyte morphology and glutamate transporter patterns with and without administration of VEGF and seizure induction

Lenzer, J. (2014) · CUNY Academic Works (City University of New York)

Graphene oxide has a neuroprotective effect against glutamate-induced excitoxicity on B35 neuroblastoma cell line

Kayhan, B., Taşdemir, Ş., İlhan, P. Ç., Görgün, C., Şendemir, A., & Şengül, G. (2015) · Anatomy (International Journal of Experimental and Clinical Anatomy) · doi:10.2399/ana.15.030

Neurodegenerative Disorders as Proteinopathies: Phenotypic Relationships

Cummings, J. L. (2005) · Research and perspectives in Alzheimer's disease · doi:10.1007/3-540-26522-8_1

Glial Glutamate and Metabolic Transporters as a Target for Neurodegenerative Therapy and Biomarkers

Philips, T., & Sattler, R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_4

Cytoskeletal dynamics in and traumatic injury of cerebellar and hippocampal neurons

Slemmer, J. E. (2005) · EUR Research Repository (Erasmus University Rotterdam)

The effect of exercise on kainic acid induced seizures

Reiss, J. I. (2009)

Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease

Rosenthal, Z. P., Kraft, A. W., Czerniewski, L. R., & Lee, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00005-3

Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA): A Genetic Linkage?

Groden, M. (2015) · Touro Scholar (Touro College)

Excitotoxicity

Dong, Y., Lin, H., Rattelle, A., Panzer, J. A., & Lynch, D. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65836-1 · Cited by 1

DETERMINING THE PATHOLOGICAL EFFECTS OF PRENATAL ALCOHOL EXPOSURE ON PERIPHERAL NEUROPATHY VIA SPINAL AND PERIPHERAL IMMUNE MECHANISMS

Sanchez, J. J. (2019) · UNM’s Digital Repository (University of New Mexico)

TMS and TMS-EEG studies on the excitability, connectivity and plasticity of the human motor cortex

Ferreri, F. (2011) · UEF eRepo (University of Eastern Finland)

Divergence in Neuronal Calcium Dysregulation in Brain Aging and Animal Models of AD

Ghoweri, A. O. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.521

Hippocampal Glutamate Level and Glutamate Aspartate Transporter (GLAST) are Up-Regulated in Senior Rat Associated with Isoflurane-Induced Spatial Learning/Memory Impairment

XuHui, X. Q., Xu, W., LiuYun, W., XuChao, Z., & Yue, J. W. (2013)

Les transporteurs vésiculaires du glutamate, VGLUT1 et VGLUT2, dans les maladies de Parkinson et d'Alzheimer

Kashani, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)

Pharmacological Modeling and Regulation of Excitatory Amino Acid Transporters (EAATs)

Agarwal, S. R. (2007) · The Mathematics Enthusiast

Glutamate Transporters

Shaw, P. J. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0595

Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration

Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_13

Faculty Opinions recommendation of Region- and Activity-Dependent Regulation of Extracellular Glutamate.

Wolf, M. E. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733232114.793545840

Cycad Consumption and Neurological Disease

Hawkes, E., Schulz, J., & Shaw, C. A. (2005) · Reviews in food and nutrition toxicity · doi:10.1201/9781420037524.ch9

Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer diseasePreprint

Brymer, K. J., Hurley, E. P., Barron, J. C., Mukherjee, B., Barnes, J. R., Nafar, F., & Parsons, M. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.21.489062

Infection-Induced Systemic Inflammation and Dementia

Osafo, N., Dei, S. O., Akwei, N. A., & Yeboah, K. O. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_2

Dancing with the ions: symport and antiport mechanisms of human glutamate transportersPreprint

Qiu, B., & Boudker, O. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.12.503774

Astrocytic modulation of the synaptic and the extrasynaptic space

Badia‐Soteras, A. (2023) · doi:10.5463/thesis.127

Widespread Changes in the Immunoreactivity of Bioactive Peptide T14 After Manipulating the Activity of Cortical Projection Neurons

Vadišiūtė, A., Garcia‐Ratés, S., Coen, C. W., Greenfield, S. A., & Molnár, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125786

Regulated cell death and inflammaging in neurodegenerative disorders

Liu, H., Wen, S., Gao, X., Wu, C., Lai, B., Zhu, J., & Kong, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00009-7

Additional file 17 of Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056383

Additional file 1 of Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer’s disease

Brymer, K. J., Hurley, E. P., Barron, J. C., Mukherjee, B., Barnes, J. R., Nafar, F., & Parsons, M. P. (2024) · Figshare · doi:10.6084/m9.figshare.26568469

Additional file 10 of Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056359

Additional file 9 of Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E. R., Dugas, J. C., Pizzo, M. E., DeVos, S. L., Earr, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056422

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer’s disease severityPreprint

Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Gaire, B. P., Jallow, O., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703406

Clinical biomarker potential of spectrin breakdown degradation products: a systematic review

Jain, S. P., Jain, S. P., Ikkurthy, N., & Silven, G. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2633459

Quantification multiplexe de biomarqueurs d’intérêt clinique et de leurs protéoformes par spectrométrie de masse. Application à l’analyse de cohortes médicales

Viodé, A. (2018) · theses.fr (ABES) · doi:10.70675/2e562182z9f48z43c1zafc3zdc79020046d3

Les astrocytes réactifs, des partenaires anti-agrégants dans la maladie de Huntington : identification des mécanismes impliqués dans le dialogue neurone-astrocyte

Abjean, L. (2019) · theses.fr (ABES) · doi:10.70675/f664e003zf93fz467eza6a3z3d953eaffe4e

Rôle du peptide amyloïde dans les maladies neurodégénératives

Combes, M. (2018) · theses.fr (ABES) · doi:10.70675/a219ef4dzbca0z4272z8bf2z74080a1976e5 · Cited by 1

Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie

Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953

Rôle central des glucocorticoïdes et de leurs récepteurs dans l’étiologie de la Maladie d’Alzheimer

Canet, G. (2020) · theses.fr (ABES) · doi:10.70675/c46cedbczd8bbz4a8eza301z82de5785048c

Robustesse du phénotype électrique des neurones dopaminergiques de la substance noire compacte à la délétion des canaux potassium Kv4.3 et SK3

Haddjeri-Hopkins, A. (2019) · theses.fr (ABES) · doi:10.70675/a38a5613zb413z4383z8a01z7a02dca49b6b

Impact of open channel blockers on the surface dynamics and organization of NMDA receptors

Fernandes, A. (2020) · theses.fr (ABES) · doi:10.70675/d12c14b2z7a80z4668z9c48z8e2c0e41c009 · Cited by 1

Evaluation du canal calcique TRPA1 comme cible thérapeutique potentielle dans la pathogénèse de la maladie d’Alzheimer

Paumier, A. (2020) · theses.fr (ABES) · doi:10.70675/46cbb4bazf458z47a7z9fefzcdb3585ce4e9

Hétérogénéité de la réactivité astrocytaire dans la maladie d'Alzheimer

Guillemaud, O. (2020) · theses.fr (ABES) · doi:10.70675/038d98c5z55ccz4754z9af9z417e3826d282

Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy

Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5

D-sérine : un maillon central de la physiopathologie amyloïde ?

Ploux, E. (2022) · theses.fr (ABES) · doi:10.70675/e7b5bba0z9abcz4325zae71z841a60892f8b

Hétérogénéité et régulation des astrocytes dans la maladie d'Alzheimer : vers des interventions ciblées sur les voies JAK2-STAT3 et NF-kB

Poulot-Becq-Giraudon, Y. (2024) · theses.fr (ABES) · doi:10.70675/0d7a8b92z8393z4d76z82a8z87efe0790346

Environmental Factors Drive Neurodegenerative Diseases Through Glutamate Excitotoxicity: A Convergent Mechanistic Pathway

He, Y., Yi, T., Min, M., Xu, K., Lin, H., Xu, R., Deng, D., & Xiao, X. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01645-y

Ischemic stroke: molecular mechanisms of blood-brain barrier dysfunction and opportunities for drug development

Ronaldson, P. T., & Davis, T. P. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00848-9

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity

Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Jallow, O., Sheyn, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202600020

BindingDB Entry 50016563: Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2.

BindingDB (2023) · UC San Diego · doi:10.7270/q2kw5m23

BindingDB Entry 50020655: A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.

BindingDB (2024) · UC San Diego · doi:10.7270/q2rx9hh3

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467